课题基金 / 基金详情

MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS

MORT1 IN APOPTOSIS OF MALIGNANT AND PRIMARY T CELLS
MORT1 在恶性和原代 T 细胞凋亡中的作用
批准号:
2377328
负责人:
ASTAR WINOTO
金额:
$20.62万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-05 至 2002-05-31

项目摘要

项目成果

ASTAR WINOTO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from the Investigator's Abstract): The long term goal of this proposed research is to understand the mechanisms of apoptosis in malignant and primary T cells. Fas is a member of the tumor necrosis factor receptor superfamily and is expressed on activated T cells and many malignant cells. Treatment with anti-Fas antibody leads to apoptosis in many but not all the tumor cells. A similar situation can also be found for T cells from different developmental stages. Immature T cells is particularly susceptible to Fas-induced apoptosis while mature T cells are quite resistant to the apoptotic-effect of anti-Fas antibodies. Mort 1 /FADD is a protein with a death domain, a protein-protein interaction domain that is also found in the cytoplasmic tail of Fas and tumor necrosis factor receptor p55. In sensitive cells, addition of anti-Fas antibodies triggers Mort1 to associate with Fas. Interference of this association process by a dominant negative Mort1 protein leads to inhibition of apoptosis. In several malignant cell lines that are resistant to Fas-mediated apoptosis, Mortl was found not to associate with Fas. Thus, Mortl-Fas association is a key step in Fas-induced apoptosis that might determine susceptibility of a cell to anti-Fas-mediated cell death. Lymphomas, thymomas and T cell hybridomas as well as transgenic and gene-targeted mutant mice will be used to understand the role of Mortl in apoptosis of malignant and primary T cells. The following specific aims are proposed. First, structure-function analysis of the Mortl protein will be performed using a Fas/Mortl chimeric protein. Second, the molecular process of Mortl/Fas association will be examined in malignant and primary T cells. Third, Mortl-deficient mice will be generated and analyzed. Fourth, the role of Mort I and one of its associating protein in apoptosis of immature T cells will be examined. The above aims should lead to a better understanding of the mechanisms of peripheral and central tolerance and why some tumor cells are resistant to Fas-induced apoptosis. The information obtained might lead to means by which apoptosis in resistant tumor cells might be induced and to halting of the onset of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Fas-associated death domain in necroptosis in vivo
The role of Fas-associated death domain in necroptosis in vivo
The role of Fas-associated death domain in necroptosis in vivo
The role of Fas-associated death domain in necroptosis in vivo
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: